Patent eligibility in the US is trending upward with two recent Federal Circuit decisions
The Supreme Court’s recent decision not to hear the Sequenom Inc v Ariosa Diagnostics Inc case disappointed many observers in the US who had been hoping that the justices would use it as means to clarify current uncertainties around Section 101 of…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.